Bupropion Binds to Two Sites in the Torpedo Nicotinic Acetylcholine Receptor Transmembrane Domain: A Photoaffinity Labeling Study with the Bupropion Analog [(125)I]-SADU-3-72

Bupropion, a clinically-used antidepressant and smoking-cessation drug, acts as a noncompetitive antagonist of nicotinic acetylcholine receptors (nAChRs). To identify its binding site(s) in nAChRs, we developed a photoreactive bupropion analog, (±)-2-(N-tert-butylamino)-3′-[(125)I]-iodo-4′-azidoprop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pandhare, Akash, Hamouda, Ayman K., Staggs, Brandon, Aggarwal, Shaili, Duddempudi, Phaneendra K., Lever, John R., Lapinsky, David J., Jansen, Michaela, Cohen, Jonathan B., Blanton, Michael P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3315157/
https://ncbi.nlm.nih.gov/pubmed/22394379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bi300101r
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados